Model-informed Drug Development in Oncology
- Friday 3 June 2016
The DDMoRe consortium concludes the series of comprehensive face-to-face courses with the first advanced course introducing the principles of model-informed drug development, covering a range of therapeutic areas, via the newly-developed DDMoRe interoperability framework platform. The Bioinformatics, Mathematical Modeling and Synthetic Biology (BMS) lab at Università degli Studi di Pavia, Italy and the Institute of Pharmacy, Freie Universitaet Berlin, Germany are happy to invite you to the following face-to-face course:
"Model-informed Drug Development in Oncology (advanced)"
- Dates: 4-8 July 2016
- Application deadline, Friday 3rd of June
- Apply here: http://www.ddmore.eu/projects/model-informed-drug-development-oncology-advanced
Venue: Departement of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Via Ferrata 5, Pavia, Italy
Intended for: PhD students and Postdoctoral fellows doing research in the quantitative life sciences field as well as other scientists in the field.
Topics: Model-informed drug development in the area of oncology with a 2-day and half introduction to the DDMoRe platform (new modelling & simulation language, model repository, interoperability framework) and 2-day and half application of the DDMoRe platform to therapeutic area oncology
Program: Lectures, hands-on sessions, group work, workshops, and participant presentations
Course directors: Charlotte Kloft (Freie Universitaet Berlin, Germany), Paolo Magni (Università degli Studi di Pavia, Italy), Zinnia Parra-Guillén (Freie Universitaet Berlin, Germany/University of Navarra, Pamplona, Spain), Lorenzo Pasotti (Università degli Studi di Pavia, Italy)
• Willing to actively participate in the course and give constructive feedback to further improve the DDMoRe products and developments
• Able to bring along a laptop that fulfils the minimum IT environment requirements specified here.
Fee: Free of charge (transport, accommodation and food not included) Maximum number of participants: 20 (If needed selection based on the registration information, with priority to PhD students/post-docs and participants from different institutions).
Application deadline: 3rd of June 2016 (Notification of acceptance 8th of June 2016)
For more information:
• DDMoRe and the ‘education & training activities’: http://www.ddmore.eu
• BMS lab: http://lab-bioinfo.unipv.it
• About the Clinical Pharmacy group at the FU Berlin:
• UNIPV: http://www.unipv.it
We warmly invite you to join us for the last public DDMoRe course: be the first trained for using the most advanced DDMoRe products!